EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy and biventricular involvement

Lishui Shen iD, Shangyu Liu iD, Zhenhao Zhang iD, Yulong Xiong, Zihao Lai, Feng Hu iD, Lihui Zheng iD, Yan Yao iD

Europace · 01.03.2024 · 26 (3)

DOI: 10.1093/europace/euae059 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Europace, online erschienen am 28.02.2024. Verfasst von Lishui Shen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Arrhythmia Center, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Fuwai Hospital,…. Hauptthemen laut MEDLINE: Arrhythmogenic Right Ventricular Dysplasia, Tachycardia, Ventricular, Catheter Ablation. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Zhejiang Medical Science and Technology Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Catheter ablation of ventricular tachycardia (VT) improves VT-free survival in ‘classic’ arrhythmogenic right ventricular cardiomyopathy (ARVC). This study aims to investigate electrophysiological features and ablation outcomes in patients with ARVC and biventricular (BiV) involvement. Methods and results We assembled a retrospective cohort of definite ARVC cases with sustained VTs. Patients were divided into the BiV (BiV involvement) group and the right ventricular (RV) (isolated RV involvement) group based on the left ventricular systolic function detected by cardiac magnetic resonance. All patients underwent electrophysiological mapping and VT ablation. Acute complete success was non-inducibility of any sustained VT, and the primary endpoint was VT recurrence. Ninety-eight patients (36 ± 14 years; 87% male) were enrolled, including 50 in the BiV group and 48 in the RV group. Biventricular involvement was associated with faster clinical VTs, a higher VT inducibility, and more extensive arrhythmogenic substrates (all P < 0.05). Left-sided VTs were observed in 20% of the BiV group cases and correlated with significantly reduced left ventricular systolic function. Catheter ablation achieved similar acute efficacy between these two groups, whereas the presence of left-sided VTs increased acute ablation failure (40 vs. 5%, P = 0.012). Over 51 ± 34 months [median, 48 (22–83) months] of follow-up, cumulative VT-free survival was 52% in the BiV group and 58% in the RV group (P = 0.353). A multivariate analysis showed that younger age, lower RV ejection fraction (RVEF), and non-acute complete ablation success were associated with VT recurrence in the BiV group.

Conclusion

Biventricular involvement implied a worse arrhythmic phenotype and increased the risk of left-sided VTs, while catheter ablation maintained its efficacy for VT control in this population. Younger age, lower RVEF, and non-acute complete success predicted VT recurrence after ablation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arrhythmogenic Right Ventricular DysplasiaTachycardia, VentricularCatheter AblationHumansMaleFemaleRetrospective StudiesTreatment Outcome

Stichwörter der Autor:innen

Arrhythmogenic right ventricular cardiomyopathyBiventricular involvementCatheter ablationVentricular tachycardia

Autor:innen und Institutionen

  • Arrhythmia Center, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Fuwai Hospital, No. 167 North Lishi Road, Xicheng District, Beijing 100037, China.
  • Department of Cardiology, Shanghai Tenth People's Hospital, Tongji University, Shanghai 200072, China.
  • Department of Cardiology, The First Hospital of Hebei Medical University, Shijiazhuang 050031, China.
  • Department of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, China.

ORCID-Profile: Lishui Shen, Shangyu Liu, Zhenhao Zhang, Feng Hu, Lihui Zheng, Yan Yao

Förderung

  • National Natural Science Foundation of China
  • Zhejiang Medical Science and Technology Program

Zitieren

APA

Shen, L., Liu, S., Zhang, Z., Xiong, Y., Lai, Z., Hu, F., Zheng, L., & Yao, Y. (2024). Catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy and biventricular involvement. Europace, 26(3). https://doi.org/10.1093/europace/euae059

Vancouver

Shen L, Liu S, Zhang Z, Xiong Y, Lai Z, Hu F, et al. Catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy and biventricular involvement. Europace. 2024;26(3). doi:10.1093/europace/euae059

BibTeX
@article{Shen2024,
  author = {Shen, Lishui and Liu, Shangyu and Zhang, Zhenhao and Xiong, Yulong and Lai, Zihao and Hu, Feng and Zheng, Lihui and Yao, Yan},
  title = {Catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy and biventricular involvement},
  journal = {Europace},
  year = {2024},
  volume = {26},
  number = {3},
  doi = {10.1093/europace/euae059}
}
Kostenlos starten →